| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |